Wednesday - December 25, 2024

Adjuvant Treatment of HER2-positive Breast Cancer

Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- HOFFMANN-LA ROCHE INC., Little Falls, New Jersey has been assigned a patent (No. US 12128103 B2, initially filed April 16, 2024) developed by Mark C. Benyunes, San Francisco, California, and Graham Alexander Ross, Hertfordshire, United Kingdom, for "Adjuvant treatment of HER2-positive breast cancer." . . .

Information Request Form

Name:
Category that best fits the type
of business or agency you are
affiliated with:		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:
I'd like to have a copy of this article mailed to me.
To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest.
If you select them please specify your keywords in the box below:
If we need to contact you please specify your preferred contact method.
Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Copyright Targeted News Service 2024